PALACE CHEMICALS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
Company Registration No. 01377241 (England and Wales)
PALACE CHEMICALS LIMITED
COMPANY INFORMATION
Directors
Mr C Clapham
Mr W Clapham
Mr J Percival
Mr S Clough
Mr S Ball
Mr D Stevenson
Ms M L Clapham
Secretary
Mr J P Greenwood
Company number
01377241
Registered office
Unit 49
Compass Industrial Park West
Speke
Liverpool
L24 1YA
Auditor
DSG Audit
Castle Chambers
43 Castle Street
Liverpool
L2 9TL
Business address
Unit 49
Compass Industrial Park West
Speke
Liverpool
L24 1YA
PALACE CHEMICALS LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Directors' responsibilities statement
5
Independent auditor's report
6 - 8
Statement of comprehensive income
9
Balance sheet
10
Statement of changes in equity
11
Notes to the financial statements
12 - 22
PALACE CHEMICALS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 AUGUST 2025
- 1 -
The directors present the strategic report for the year ended 31 August 2025.
Principal activities
The principal activities of the company in the year under review were the manufacture and sale of ceramic tile adhesives and building chemical products supplied to the building and DIY industry.
Review of the business
As shown in the company’s statement of comprehensive income, revenue for the year has increased by 11.2%. In the challenging market conditions that existed in the year, in addition to continued pressure on employment costs, the directors consider this to be a very strong performance.
The company continues to maintain strong controls over fixed costs and other overheads whilst also investing in manufacturing capability, quality, marketing and research and development to enable it to achieve its profitability targets.
Principal risks and uncertainties
There are a number of risks and uncertainties that can impact on the performance of Palace Chemicals Limited, some of which are beyond the control the company.
The directors consider the most significant risks faced by the company are the continuing knock on effect of the UK’s withdrawal from the European Union and the continued unrest in the Ukraine which has created an energy crisis increasing the cost of energy substantially. These risks are managed by the Board as a whole and are the subject of regular internal review meetings and investments made to mitigate such risks are effective.
The company monitors market trends and risks on an ongoing basis and takes corrective action as and when required.
Competitive pressure in all the markets it operates in are an ongoing risk to the company. To manage this risk the company maintains strong relationships with its customers with high levels of customer service and product quality, range and value.
Fluctuations in the price and supply of key raw materials may also affect the profitability of the business. Purchasing policies and practices mitigate, where practicable, these risks. Post year end the company has continued to hold sufficient stock to provide stability.
Liquidity, foreign currency and credit risks are set out in the directors’ report.
Key performance indicators
Key performance indicators continue to be used throughout the business, and the financial indicators such as turnover, gross profit margin, profit before tax, trade debtors and stock levels are set out in the body of the accounts.
The cash balance at the year end was positive and the company maintains strong cash control which has enabled it to meet its obligations to suppliers and other creditors as they fall due.
The directors also consider other non-financial indicators to monitor the performance of the business. These include:
The company’s ability to react to market conditions with a flexible approach to their manufacturing and distribution capabilities.
PALACE CHEMICALS LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 2 -
Research and development - The company continues with a robust policy to develop new products to enhance its position in the marketplace.
Employees - The company continues to invest in its strategies for the training, development and retention of employees. Average headcount for 2025 was 97 (2024: 86).
Mr C Clapham
Director
12 December 2025
PALACE CHEMICALS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
The directors present their annual report and financial statements for the year ended 31 August 2025.
Results and dividends
The results for the year are set out on page 9.
Ordinary dividends were paid to Micrown Limited amounting to £1,382,845.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr C Clapham
Mr W Clapham
Mr J Percival
Mr S Clough
Mr S Ball
Mr D Stevenson
Ms M L Clapham
Qualifying third party indemnity provisions
The company has made qualifying third party indemnity provisions for the benefit of its directors during the year. These provisions remain in force at the reporting date.
Financial instruments
Liquidity risk
The company manages its cash and borrowing requirements in order to maximise interest income and minimise interest expense, whilst ensuring the company has sufficient liquid resources to meet the operating needs of the business.
Foreign currency risk
The company’s principal foreign currency exposures arise from trading with overseas companies. Company policy permits but does not demand that these exposures may be hedged in order to fix the cost in sterling.
Credit risk
Investments of cash surpluses are made through banks and companies which must fulfil credit rating criteria approved by the Board.
All customers who wish to trade on credit terms are subject to credit verification procedures. Trade debtors are monitored on an ongoing basis and provision is made for doubtful debts where necessary.
Future developments
The company plans to continue to grow the business and its reputation throughout the industry. The external commercial environment is expected to remain competitive but management remain confident that the company will maintain or increase its market share going forward.
Auditor
The auditor, DSG Audit, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Strategic report
The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. The company has done so in respect of its principal activities.
PALACE CHEMICALS LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 4 -
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
On behalf of the board
Mr C Clapham
Director
12 December 2025
PALACE CHEMICALS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 AUGUST 2025
- 5 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
PALACE CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PALACE CHEMICALS LIMITED
- 6 -
Opinion
We have audited the financial statements of Palace Chemicals Limited (the 'company') for the year ended 31 August 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 August 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
PALACE CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PALACE CHEMICALS LIMITED (CONTINUED)
- 7 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
Capability of the audit in detecting irregularities, including fraud
Discussions with and enquiries of management and those charged with governance were held with a view to identifying those laws and regulations that could be expected to have a material impact on the financial statements. During the engagement team briefing, the outcomes of these discussions and enquiries were shared with the team, as well as consideration as to where and how fraud may occur in the entity. The following laws and regulations were identified as being of significance to the entity:
Those laws and regulations considered to have a direct effect on the financial statements include UK financial reporting standards, Company Law, Tax and Pensions legislation, and distributable profits legislation.
Those laws and regulations for which non-compliance may be fundamental to the operating aspects of the business and therefore may have a material effect on the financial statements include environmental regulations, health and safety legislation, trades description act and employment legislation.
Audit procedures undertaken in response to the potential risks relating to irregularities (which include fraud and non-compliance with laws and regulations) comprised of: enquiries of management and those charged with governance as to whether the entity complies with such laws and regulations; enquiries with the same concerning any actual or potential litigation or claims; inspection of relevant legal correspondence; testing the appropriateness of journal entries; reviewing post year end payments for evidence of claims pay outs and the performance of analytical review to identify unexpected movements in account balances which may be indicative of fraud.
No instances of material non-compliance were identified. However, the likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity’s controls, and the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As explained above, there is an unavoidable risk that material misstatements may not be detected, even though the audit has been planned and performed in accordance with ISAs (UK).
PALACE CHEMICALS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PALACE CHEMICALS LIMITED (CONTINUED)
- 8 -
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Andrew Moss BA FCA (Senior Statutory Auditor)
For and on behalf of DSG Audit, Statutory Auditor
Chartered Accountants
Castle Chambers
43 Castle Street
Liverpool
L2 9TL
12 December 2025
PALACE CHEMICALS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 AUGUST 2025
- 9 -
2025
2024
Notes
£
£
Turnover
3
32,440,783
29,179,868
Cost of sales
(19,891,504)
(18,126,742)
Gross profit
12,549,279
11,053,126
Distribution costs
(4,698,566)
(4,509,174)
Administrative expenses
(2,477,117)
(2,436,960)
Other operating income
99,773
Operating profit
4
5,473,369
4,106,992
Interest receivable and similar income
7
812,392
877,575
Profit before taxation
6,285,761
4,984,567
Tax on profit
9
(1,608,615)
(1,138,535)
Profit for the financial year
4,677,146
3,846,032
PALACE CHEMICALS LIMITED
BALANCE SHEET
AS AT
31 AUGUST 2025
31 August 2025
- 10 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
10
Tangible assets
11
5,402,055
4,852,079
Current assets
Stocks
12
3,385,660
3,239,741
Debtors
13
9,539,810
8,671,129
Cash at bank and in hand
22,567,254
20,488,000
35,492,724
32,398,870
Creditors: amounts falling due within one year
14
(5,055,064)
(4,739,647)
Net current assets
30,437,660
27,659,223
Total assets less current liabilities
35,839,715
32,511,302
Provisions for liabilities
Deferred tax liability
15
628,790
594,678
(628,790)
(594,678)
Net assets
35,210,925
31,916,624
Capital and reserves
Called up share capital
17
20,000
20,000
Revaluation reserve
165,920
170,800
Profit and loss reserves
35,025,005
31,725,824
Total equity
35,210,925
31,916,624
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 12 December 2025 and are signed on its behalf by:
Mr C Clapham
Director
Company registration number 01377241 (England and Wales)
PALACE CHEMICALS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2025
- 11 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 September 2023
20,000
175,680
28,639,832
28,835,512
Year ended 31 August 2024:
Profit and total comprehensive income
-
-
3,846,032
3,846,032
Dividends
8
-
-
(764,920)
(764,920)
Transfers
-
(4,880)
4,880
-
Balance at 31 August 2024
20,000
170,800
31,725,824
31,916,624
Year ended 31 August 2025:
Profit and total comprehensive income
-
-
4,677,146
4,677,146
Dividends
8
-
-
(1,382,845)
(1,382,845)
Transfers
-
(4,880)
4,880
-
Balance at 31 August 2025
20,000
165,920
35,025,005
35,210,925
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 12 -
1
Accounting policies
Company information
Palace Chemicals Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 49, Compass Industrial Park West, Speke, Liverpool, L24 1YA.
1.1
Basis of preparation
The financial statements are prepared under the historical cost convention modified to include the revaluation of leasehold land and buildings at deemed cost.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
The financial statements of the company are consolidated in the financial statements of Micrown Limited. These consolidated financial statements are available from its registered office, Unit 49 Compass Industrial Park West, Speke, Liverpool, L24 1YA.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Turnover represents amounts derived from ordinary activities, and stated after trade discounts, other sales taxes and net of VAT.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on despatch of the goods or upon collection), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Long leasehold property
2% straight line
Plant and machinery
15% reducing balance and 2% on cost
Office furniture & fittings
15% reducing balance
Motor vehicles
25% reducing balance
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 13 -
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 14 -
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 15 -
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.13
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 16 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.
Depreciation of fixed assets
Management review the useful economic life and residual value of their fixed assets. The assets are then depreciated over their useful economic life less any residual value. Both the useful economic life and residual value of an asset are a matter of management judgement. Details of the depreciation rates can be found in Note 1.4 to these financial statements.
3
Turnover and other revenue
An analysis of the company's turnover is as follows:
2025
2024
£
£
Turnover analysed by class of business
Sale of goods
32,440,783
29,179,868
2025
2024
£
£
Turnover analysed by geographical market
United Kingdom
28,698,104
24,652,058
Europe
3,136,714
3,507,271
Middle East
605,471
1,019,012
Other
494
1,527
32,440,783
29,179,868
2025
2024
£
£
Other revenue
Interest income
812,392
877,575
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 17 -
4
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Auditors' remuneration
25,590
24,400
Depreciation of tangible fixed assets
570,359
370,206
(Profit)/loss on disposal of tangible fixed assets
(11,624)
4,441
Operating lease charges
96,159
33,051
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Management
9
9
Production
65
54
Selling and distribution
10
9
Administration
13
14
Total
97
86
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
3,958,875
3,662,565
Social security costs
481,999
393,368
Pension costs
49,135
42,905
4,490,009
4,098,838
6
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
1,242,382
1,264,436
Company pension contributions to defined contribution schemes
4,463
4,463
1,246,845
1,268,899
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 4 (2024 - 4).
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
6
Directors' remuneration
(Continued)
- 18 -
Remuneration disclosed above include the following amounts paid to the highest paid director:
2025
2024
£
£
Remuneration for qualifying services
350,653
335,567
The directors are considered to be the key management personnel.
7
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
812,392
877,575
8
Dividends
2025
2024
£
£
Interim paid
1,382,845
764,920
9
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
1,569,494
905,764
Adjustments in respect of prior periods
5,009
(9,417)
Total current tax
1,574,503
896,347
Deferred tax
Origination and reversal of timing differences
34,112
242,188
Total tax charge
1,608,615
1,138,535
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
9
Taxation
(Continued)
- 19 -
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
6,285,761
4,984,567
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
1,571,440
1,246,142
Adjustments in respect of prior years
5,009
(9,417)
Permanent capital allowances in excess of depreciation
57,109
(98,190)
Research and Development relief
(24,943)
Taxation charge for the year
1,608,615
1,138,535
10
Intangible fixed assets
Goodwill
£
Cost
At 1 September 2024 and 31 August 2025
100,000
Amortisation and impairment
At 1 September 2024 and 31 August 2025
100,000
Carrying amount
At 31 August 2025
At 31 August 2024
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 20 -
11
Tangible fixed assets
Long leasehold property
Plant and machinery
Office furniture & fittings
Motor vehicles
Total
£
£
£
£
£
Cost or valuation
At 1 September 2024
2,489,235
7,633,853
743,939
570,172
11,437,199
Additions
856,288
184,202
107,671
1,148,161
Disposals
(95,595)
(95,595)
At 31 August 2025
2,489,235
8,490,141
928,141
582,248
12,489,765
Depreciation and impairment
At 1 September 2024
685,308
5,186,028
515,072
198,712
6,585,120
Depreciation charged in the year
49,785
365,032
46,575
108,967
570,359
Eliminated in respect of disposals
(67,769)
(67,769)
At 31 August 2025
735,093
5,551,060
561,647
239,910
7,087,710
Carrying amount
At 31 August 2025
1,754,142
2,939,081
366,494
342,338
5,402,055
At 31 August 2024
1,803,927
2,447,825
228,867
371,460
4,852,079
Land and buildings are carried at valuation. If land and buildings were measured using the cost model, the carrying amounts would have been approximately £1,588,222 (2024: £1,633,127), being cost £2,389,235 (2024: £2,389,235) and depreciation £801,013 (2024: £756,108).
12
Stocks
2025
2024
£
£
Raw materials and consumables
2,633,996
2,525,896
Finished goods and goods for resale
751,664
713,845
3,385,660
3,239,741
An impairment loss of £109,844 (2024: £51,180) has been recognised against stock.
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 21 -
13
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
7,742,335
7,073,376
Corporation tax recoverable
99,773
Amounts owed by group undertakings
1,209,622
1,209,622
Prepayments and accrued income
488,080
388,131
9,539,810
8,671,129
An impairment loss of £17,194 (2024: £119,801) has been recognised against trade debtors.
Amounts owed by group undertakings are interest free, hence have no fixed date of repayment and are repayable upon demand.
14
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,879,922
2,058,119
Corporation tax
903,233
428,730
Other taxation and social security
799,367
702,648
Accruals and deferred income
1,472,542
1,550,150
5,055,064
4,739,647
15
Deferred taxation
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
Liabilities
Liabilities
2025
2024
Balances:
£
£
ACAs
633,579
595,563
Retirement benefit obligations
(4,789)
(885)
628,790
594,678
2025
Movements in the year:
£
Liability at 1 September 2024
594,678
Charge to profit or loss
34,112
Liability at 31 August 2025
628,790
PALACE CHEMICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 22 -
16
Retirement benefit schemes
Defined contribution schemes
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
The charge to profit or loss in respect of defined contribution schemes was £49,135 (2024: £42,905).
17
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
"A" Ordinary shares of £1 each
14,650
14,650
14,650
14,650
"B" Ordinary shares of £1 each
5,350
5,350
5,350
5,350
20,000
20,000
20,000
20,000
The separate classes of shares shall be considered as being identical in all respects except for dividend levels which are set for each class.
18
Capital commitments
Amounts contracted for but not provided in the financial statements:
2025
2024
£
£
Acquisition of tangible fixed assets
97,481
-
19
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2025
2024
£
£
Within 1 year
96,120
85,464
Years 2-5
350,894
328,549
After 5 years
83,922
447,014
497,935
20
Ultimate controlling party
The parent company is Micrown Limited, a company incorporated in Great Britain and registered in England and Wales. The registered office is Unit 49 Compass Industrial Park West, Speke, Liverpool, L24 1YA. Micrown Limited prepares consolidated financial statements which includes Palace Chemicals Limited.
The smallest and largest group into which the results of this entity are consolidated is that headed by Micrown Limited.
2025-08-312024-09-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.300Mr C ClaphamMr W ClaphamMr J PercivalMr S CloughMr S BallMr D StevensonMs M L ClaphamMr J P Greenwood013772412024-09-012025-08-3101377241bus:Director12024-09-012025-08-3101377241bus:Director22024-09-012025-08-3101377241bus:Director32024-09-012025-08-3101377241bus:Director42024-09-012025-08-3101377241bus:Director52024-09-012025-08-3101377241bus:Director62024-09-012025-08-3101377241bus:Director72024-09-012025-08-3101377241bus:CompanySecretary12024-09-012025-08-3101377241bus:RegisteredOffice2024-09-012025-08-31013772412025-08-31013772412023-09-012024-08-3101377241core:RetainedEarningsAccumulatedLosses2023-09-012024-08-3101377241core:RetainedEarningsAccumulatedLosses2024-09-012025-08-3101377241core:IntangibleAssetsOtherThanGoodwill2025-08-3101377241core:IntangibleAssetsOtherThanGoodwill2024-08-3101377241core:Goodwill2025-08-3101377241core:Goodwill2024-08-31013772412024-08-3101377241core:PlantMachinery2025-08-3101377241core:FurnitureFittings2025-08-3101377241core:MotorVehicles2025-08-3101377241core:LandBuildings2024-08-3101377241core:PlantMachinery2024-08-3101377241core:FurnitureFittings2024-08-3101377241core:MotorVehicles2024-08-3101377241core:CurrentFinancialInstruments2025-08-3101377241core:CurrentFinancialInstruments2024-08-3101377241core:ShareCapital2025-08-3101377241core:ShareCapital2024-08-3101377241core:RevaluationReserve2025-08-3101377241core:RevaluationReserve2024-08-3101377241core:RetainedEarningsAccumulatedLosses2025-08-3101377241core:RetainedEarningsAccumulatedLosses2024-08-3101377241core:ShareCapital2023-08-3101377241core:RevaluationReserve2023-08-3101377241core:RetainedEarningsAccumulatedLosses2023-08-3101377241core:ShareCapitalOrdinaryShareClass22025-08-3101377241core:ShareCapitalOrdinaryShareClass22024-08-3101377241core:ShareCapitalOrdinaryShareClass32025-08-3101377241core:ShareCapitalOrdinaryShareClass32024-08-3101377241core:ShareCapitalOrdinaryShares2025-08-3101377241core:ShareCapitalOrdinaryShares2024-08-3101377241core:RevaluationReserve2023-09-012024-08-3101377241core:RevaluationReserve2024-09-012025-08-3101377241core:LandBuildingscore:LongLeaseholdAssets2024-09-012025-08-3101377241core:PlantMachinery2024-09-012025-08-3101377241core:FurnitureFittings2024-09-012025-08-3101377241core:MotorVehicles2024-09-012025-08-3101377241core:UKTax2024-09-012025-08-3101377241core:UKTax2023-09-012024-08-310137724112024-09-012025-08-310137724112023-09-012024-08-3101377241core:Goodwill2024-08-3101377241core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-08-3101377241core:PlantMachinery2024-08-3101377241core:FurnitureFittings2024-08-3101377241core:MotorVehicles2024-08-31013772412024-08-3101377241core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-08-3101377241core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-09-012025-08-3101377241bus:OrdinaryShareClass22024-09-012025-08-3101377241bus:OrdinaryShareClass32024-09-012025-08-3101377241bus:OrdinaryShareClass22025-08-3101377241bus:OrdinaryShareClass22024-08-3101377241bus:OrdinaryShareClass32025-08-3101377241bus:OrdinaryShareClass32024-08-3101377241bus:AllOrdinaryShares2025-08-3101377241bus:AllOrdinaryShares2024-08-3101377241core:WithinOneYear2025-08-3101377241core:WithinOneYear2024-08-3101377241core:BetweenTwoFiveYears2025-08-3101377241core:BetweenTwoFiveYears2024-08-3101377241core:MoreThanFiveYears2025-08-3101377241core:MoreThanFiveYears2024-08-3101377241bus:PrivateLimitedCompanyLtd2024-09-012025-08-3101377241bus:FRS1022024-09-012025-08-3101377241bus:Audited2024-09-012025-08-3101377241bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP